TrialJournal of clinical psychopharmacology

A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder.

Azmi Nasser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.